NCT07694063Recruiting
Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine
A Randomized Controlled Trial of an Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine
Source: ClinicalTrials.gov · Last updated 9 Jul 2026
Brief summary (registry, in English)
This randomized controlled trial aims to evaluate the effectiveness and feasibility of an online Hatha yoga program as an adjunct (add-on) therapy for patients with high-frequency episodic migraine. Participants will be randomly assigned to either an intervention group receiving a 12-week home-based online Hatha yoga program in addition to usual pharmacological treatment, or a control group receiving usual pharmacological care only. Outcomes include migraine frequency, pain intensity, functional disability, sleep quality, psychological symptoms, and adherence.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 24 Jun 2026
- Start date
- 27 Jan 2026
- Primary completion date
- 30 Oct 2026
- Lead sponsor
- University of Seville
- Diseases
- Migraine
- NCT number
- NCT07694063
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 27 Jan 2026 to the primary completion date, 30 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of more than one preventive migraine medication
Other illness
- Other significant neurological disorders
- Severe psychiatric conditions affecting participation
Other
- Medical contraindications to moderate physical activity
- Chronic migraine (≥15 headache days/month)
- Lack of Spanish language comprehension
- Lack of internet access or digital skills for online intervention
Who the study is looking for
- Adults aged 18-65 years
- Diagnosis of episodic high-frequency migraine according to ICHD criteria
- Diagnosis confirmed by a neurologist
- At least 1-year history of migraine
- Receiving stable pharmacological treatment for ≥3 months before enrollment
- Willing to maintain stable medication during the study
- Ability to understand study procedures and complete assessments
- Signed informed consent
- Willingness to be randomized
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Virgen del Rocio Coordinator of this site? Confirm its status | Seville | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.